L. Ronconi National University of Ireland Galway Galway Ireland Biography
Biography of L. Ronconi
Dr. Ronconi (MChem, PhD, MRSC) obtained theMChemDegree (2000) and the PhD in Chemistry (2004) from the University of Padova (Italy). After one year of postdoctoral research at the sameuniversity, he took up a Marie Curie postdoctoral fellowship and, afterwards, a Körber Foundation postdoctoralfellowship at the University of Edinburgh (UK).
In 2008he was appointed Assistant Professor of Chemistry at the University of Padova (Italy), and since2013 he is Lecturer in Chemistry at the National University of Ireland Galway (Ireland).
His current researchinterests focus on the design of metal-based anticancer and imaging agents targeting specific biomarkers up-regulated in tumor cells for the targeted chemotherapy and diagnosis.
Anna Sapino University of Turin Turin Italy Biography
Biography of Anna Sapino
Anna Sapino obtained her Medical Degree (M.D.) at the University of Turin (IT) and the specialization in Surgical Pathology at the University of Milan (IT). She is full professor of Pathology at the University of Torino. Currently Dr. Sapino is the Scientific Director of the Candiolo Cancer Institute Fondazione del Piemonte per l’Oncologia- FPO-IRCCS. She has published more than 280 scientific works.
Amedeo Amedei University of Florence Firenze Italy Biography
Biography of Amedeo Amedei
Amedeo Amedei in 1996 he graduated with full marks and honours in Biology at Florence University. He started his scientific career studying the role of Th1/Th2 lymphocytes in GVHD, atopic dermatitis and kidney rejection. After he examined the role of Helicobacter pylori-specific immune response in gastric diseases. In 2003 began his doctor’s degree in "Clinical and Sperimental Medicine". In 2005 he became researcher at Department of Experimental and Clinical Medicine (University of Florence), where in 2015 he was appointed Associate Professor. Recently, the Prof. Amedei has focused his scientific interests on the cancer immunology. The great quality of his international profile is documented by scientific production: 126 peer reviewed articles (3474 Citations), 6 book chapters and one patent. The Prof. Amedei is serving as an editorial board member of 56 international journals and carries out activities as scientific reviewer for international research projects of private and public entities.
Vasso Apostolopoulos Victoria University Melbourne Australia
Alfredo Budillon National Cancer Institute - G. Pascale Napoli Italy Biography
Biography of Alfredo Budillon
Dr. Budillon graduated in Medicine and passed the Specialty Certification in Oncology at University Federico II, Naples, Italy. He obtained the PhD in Oncology from University G. D’Annunzio of Chieti, Italy, and a Master degree in Health economy, Management and Bioethics. Dr. Budillon is the chief of Experimental Pharmacology, National Cancer Institute G. Pascale, Naples, Italy. He is also Adjunct Professor in Temple University’s College of Science and Technology, Philadelphia, PA, USA, and author of more that 130 publications and of a patent. He is also member of the Editorial Advisory Board of Reviews On Recent Clinical Trials, published by Bentham Science.
Andrew M. Chan The Chinese University of Hong Kong Shatin Hong Kong Biography
Biography of Andrew M. Chan
Dr. Andrew M. Chan is a Professor and Chief of the Cancer Biology & Experimental Therapeutics Programme at the School of Biomedical Sciences of The Chinese University of Hong Kong. He obtained his Ph.D. degree from The Institute of Cancer Research in London in 1989 and conducted postdoctoral training at the US National Cancer Institute. He joined the Mount Sinai School of Medicine as an assistant professor and was recruited to the Medical College of Wisconsin as a full professor. Dr. Chan published 61 peer-reviewed articles in high impact journals including Science, Nature Genetics, PNAS, Cancer Cell, and Blood.
Chung-Yi Chen Fooyin University Kaohsiung Taiwan Biography
Biography of Chung-Yi Chen
President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. President Chen was just over 45 years old, but his work has more than 200 papers, Taiwan one of the young talents. Professor Chen was invited more than 70 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award.
Zhe-Sheng Chen St. John's University NY USA Biography
Biography of Zhe-Sheng Chen
Dr. Chen obtained a doctorate (Ph.D.) in Pharmacology from the Kagoshima University, Japan. Dr. Chen also holds an MD degree from Guangdong Medical and Pharmaceutical College and a Master degree in Toxicology from Sun Yat-Sen Medical University, China. Currently Dr. Chen is a Professor at St. John’s University College of Pharmacy and Health Sciences. Dr. Chen is also a director of Institute for Biotechnology at St. John’s University. He has published more than 180 scientific publications. Dr. Chen is the founding Editor in Chief of Journal of Cancer Research Updates and is also the Editor-in-Chief of Journal of New Developments in Chemistry, an editor of African Journal of Pharmacy and Pharmacology. He is also an editorial board member of 26 journals and a reviewer of more than 170 peer reviewed journals. As a consultant to pharmaceutical, biotechnology and health industry organizations, Dr. Chen commands invitations for more than 150 presentations, keynote addresses, and conference chairman. Dr. Chen is also a grant reviewer of NIH, Chinese National Natural Science Foundation (China), The Genesis Oncology Trust (New Zealand), National Science Centre (Poland), The Government of the Hong Kong Special Administrative Region (HKSAR) Grant, Hong Kong (China), the Hungarian Scientific Research Fund (OTKA) (Hungary), the Netherlands Organisation for Scientific Research (NWO) (Netherlands), and the Czech Science Foundation (Czech) etc.
Irena Kostova Medical University Sofia Bulgaria Biography
Biography of Irena Kostova
Graduated from Mendeleev Univ., Moscow. PhD and DSc Theses by MU-Sofia.
Editor: METAL-BASED DRUGS; ASIAN CHEM LETT; INT J DRUG DISCOV; INT J
CURR CHEM; REC PAT ANTI–CANCER DRUG DISCOV; J PHARMA&PHARM SCI.
Member of Editorial Boards: ANTI-CANCER AGENTS MED CHEM; WORLD J VIROL; IND J PURE&APPL PHYS; THE OPEN CANCER JOURNAL; REC PAT ANTI-INF
DRUG DISCOV; INFECT & DRUG RES; BRIT J MED MED RES; INT J CHEM;
INT J ENVIR SCI; DATASET PAPERS CHEM; PEERTECHZ J MED CHEM RES.
Published over 130 papers (citations>3000; IF>140; h-index: 27). More details:
Terry Lichtor Rush University Medical Center IL United States Biography
Biography of Terry Lichtor
Terry Lichtor, MD, PhD is a practicing neurosurgeon. He has a number of research interests, and his brain tumor work is largely focused on the development of a DNA vaccine for treatment of primary and metastatic intracerebral tumors. In particular Dr. Lichtor has shown that vaccines prepared by transfer of DNA from the tumor into a highly immunogenic cell line stimulates an antitumor immune response which may be efficacious in the treatment of patients with brain tumors. Other research interests include developing a passive immunotherapeutic strategy for treatment of Alzheimer’s Disease. In addition, he has been involved in the development of a non-invasive MRI technique to measure intracranial pressure and brain compliance, and has been exploring the efficacy of this modality in managing a variety of patients with neurologic problems where intracranial pressure is an issue. Dr. Lichtor is a member of the neurosurgery faculty at Rush University Medical Center in Chicago, Illinois.
Luca Munaron University of Torino Torino Italy Biography
Biography of Luca Munaron
Dr. Luca Munaron obtained his Ph.D. in Physiology from the University of Milan (Italy) and is currently Associate Professor in Physiology at the University of Turin (Italy).
He is a member of the Editorial Board of several international journals and served as an Editor for special issues.
Dr. Munaron published more than 70 full papers on indexed journals and its work reached more than 1800 citations.
Jianyu Rao University of California at Los Angeles CA USA
Hongbin Sun China Pharmaceutical University Nanjing China Biography
Biography of Hongbin Sun
Dr. Sun obtained a doctorate (Ph.D.) in Medicinal Chemistry from China pharmaceutical University in 1995. Currently Dr. Sun is a Professor in China pharmaceutical University. He has published more than 180 scientific publications and is the inventor of more than 30 patent applications. Dr. Sun’s major research interest is target verification and drug discovery for metabolic diseases and cancer. The leading drug candidate developed by Dr. Sun is Vicagrel (an anti-platelet agent in phase I clinical trial).
J.-Y. WINUM University of Montpellier Montpellier France Biography
Biography of J.-Y. WINUM
Dr. Winum received his PhD in chemistry from the University of Montpellier (France), in 1998. He then worked as a postdoctoral fellow in the Chemistry Department of Georgetown University (Washington, DC) and in the Organic Chemistry Department of the University of Geneva (Switzerland). In 1999, he joined the Department of Chemistry of the University of Montpellier, where he is now an Associate Professor. He has published more than 135 scientific papers and is a named inventor of 6 patents. Beside being Regional Editor of Recent Patents in Anti-cancer Drug Discovery, he is also associate editor of Journal of Enzyme Inhibition and Medicinal Chemistry and editorial board member of Expert Opinion on Therapeutic Patents, Anticancer Agents in Medicnal Chemistry and Current Organic Chemistry.
Frontiers Section Editors
A. Amin United Arab Emirates University Al-Ain UAE Biography
Biography of A. Amin
Amr Amin has completed his PhD at University of Illinois at Chicago, and received a post-doctoral training in the field of molecular genetics at the University of Pennsylvania School of Medicine. He started his academic career at UAE University where he serves now as a Full Professor of Cell Biology. Amr’s research focuses on ways to control cancer, particularly liver cancer. He published many research articles and reviews and serves as reviewer and as an editorial member of many specialized peer-reviewed journals. He is also a member of many specialized societies and the sole recipient of national and international scientific awards.
Dr. Q. Ping Dou is Professor of Oncology, Pharmacology and Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI. He obtained his Ph.D. degree in chemistry from Rutgers University, and postdoctoral training at Dana-Farber Cancer Institute and Harvard Medical School. Dr. Dou has extensive experience in the fields of molecular targeting, drug discovery, chemoprevention, natural products, proteasome inhibitors, cell cycle and apoptosis, and has published ~231 peer-reviewed research and review articles, many of those in journals of the highest quality. Dr. Dou is also an inventor of multiple US and international patents.
Section: Antibodies and Peptides in Cancer Therapy
Prof. Hang Fai (Henry) Kwok currently holds the positions of Associate Professor and Consultant of Histopathology Core in the Faculty of Health Sciences at the University of Macau. He also serves as a Visiting Scientist in the CRUK Cambridge Institute at the University of Cambridge. His research interests focus on protease and venom biochemistry with biologics development to pursue novel therapeutic, prognostic, and diagnostic approaches in the treatment of cancer. Prof. Kwok has authored over 65 research and review articles. Dr. Kwok is also an inventor of multiple international patents, and currently serves as member of editorial board/guest editor in four international journals.
Section: Molecular Responses to Anticancer Drugs
A. Shtil Blokhin Cancer Center Moscow Russia Biography
Biography of A. Shtil
Dr. A. Shtil received his MD degree in Orenburg State Medical Institute and PhD in Moscow Research Institute of Otorhinolaryngology. In 1994-2002 he worked in the University of Illinois at Chicago, Lee Moffitt Cancer Center and Sloan-Kettering Cancer Institute, studying the mechanisms of multidrug resistance and altered drug response in cancer (with I.Roninson, W.Dalton and K.Scotto). After returning to Blokhin Cancer Center he established a new laboratory of tumor cell death with broad interests in cancer biology. The laboratory is studying the molecular mechanisms of cytocidal effects of small molecular weight compounds as perspective anticancer drug candidates. Our particular interest is novel DNA ligands, including the derivatives of anthraquinone and porphyrins that target the double helix and complex DNA structures. We also investigate the anti-apoptotic and pro-proliferation protein kinase Pim-1, the druggable target for newly developed indole based inhibitors. International cooperation includes the European Consortium “Protein kinases – Novel Drug Targets of Post Genomic Era” and contacts with grroups in the United States, France, Japan and Taiwan. Dr. Shtil has authored 150 scientific papers, review articles and a number of patents. He is member of editorial boards in four international journals.
Section: Cancer Stem Cells and Chemoresistance
W. Wang University of Wolverhampton Wolverhampton, WV1 1LY UK Biography
Biography of W. Wang
Dr. Wang is a Professor of Experimental Cancer Therapeutics in University of Wolverhampton, UK and Director of Disulfican Ltd. His research interests are focused on study of cancer cell chemoresistance. He is interested in the relationship between hypoxia-triggered NF-κB pathway activation, cancer stem-like cells and de novo/acquired chemoresistance. His group has been trying to identify some clinically available medicine with inhibiting effect on NF-κB pathway and cancer stem-like cells to target cancer cells and and sensitise cancer cells to conventional anticancer drugs. Dr Wang has more than 100 publications and several patents in anticancer drug development.
Book Review Editor
Sergei N. Orlov Laboratory of Biomembranes Lomonosov Moscow State University Moscow Russia
Editorial Board Members
A.M. Almerico University of Palermo Palermo Italy Biography
Biography of A.M. Almerico
Anna Maria Almerico graduated in chemistry with full marks and honours in 1977 (University of Palermo). During her academic career, she was visiting Professor at the School of Chemical Sciences, UEA (UK, 1983–1984), at the College of Pharmacy – OSU (USA, 1986–1987), at Masaryk University – Brno (Czech Republic, 1993). Currently she is Full Professor of Medicinal Chemistry at the University of Palermo. Her scientific interests are mainly devoted to the design, synthesis and evaluation of biological properties of new heterocyclic compounds related to well-known anticancer/antiviral/antiparasitic drugs. She is coauthor of more than 130 papers and 160 communications to Congresses.
R. Aneja Georgia State University GA USA Biography
Biography of R. Aneja
Ritu Aneja is a Professor of Cancer Biology at Georgia State University where she is also the Director of Graduate Studies in Biologyand Director of the Molecular Basis of Disease(MBD) Program that fosters interdisciplinary research. She has published over 125 papers in peer-reviewed journals and has presented more than 50 invited talks at various prominent forums in the US, China, India, Africa, and Europe. Two years ago, sheco-founded the International Consortium for Advancing Research on Triple Negative Breast Cancer (ICART; www.theicart.org)with the vision of revitalizing research focused on this understudied, highly aggressive and complex subtype of breast cancer.
A. Arcaro Bern University Hospital Bern Switzerland Biography
Biography of A. Arcaro
Alexandre Arcaro is a group leader at Bern University Hospital in Switzerland. He graduated in biology at the University of Lausanne (Switzerland) in 1992 and obtained a Ph.D. in natural sciences from the University of Fribourg (Switzerland) in 1995. He was then a postdoctoral fellow at the Ludwig Institute for Cancer Research, University College London, United Kingdom, from 1996 to 1997 and at the Ludwig Institute for Cancer Research, Lausanne Branch, from 1998 to 2000. From 2000 to 2003 he was then a lecturer at Imperial College Faculty of Medicine, London, United Kingdom. He was a group leader at the University Children’s Hospital Zurich, Switzerland, from 2003 to 2009. His research work is focused on the study of receptor tyrosine kinase signaling and PI3K isoforms in human cancer.
A. Bateman Research Institute of McGill University Health Centre Montreal, QC Canada
A. Bishayee Larkin University Miami, FL USA Biography
Biography of A. Bishayee
Dr. Bishayee received a Bachelor of Pharmacy, Master of Pharmacy, and Ph.D. (Pharmacy) from Jadavpur University, Kolkata, India. Dr. Bishayee performed post-doctoral research at Rutgers University, Newark, New Jersey (formerly University of Medicine and Dentistry of New Jersey) and completed a fellowship in Academic Medicine from Northeast Ohio Medical University. Dr. Bishayee’s primary research interest during last two decades encompasses cancer biology, cancer therapeutics, and cancer prevention. Dr. Bishayee is serving as Editor-in-Chief of the Journal of Natural Products in Cancer Prevention and Therapy as well as editorial board member and reviewer of more than 60 reputed journals.
I. Blanco Catalan Institute of Oncology Barcelona Spain
J. Brunel Aix-Marseille University Marseille France Biography
Biography of J. Brunel
Jean Michel Brunel was graduated from the School of Chemistry of Marseille (France) in 1991. He obtained his Ph.D. degree in 1994 from Université Aix Marseille in the field of asymmetric organophosphorus chemistry. In 1994, he joined the group of Pr. H. B. Kagan (Université Paris Sud) as a postdoctoral fellow working on the enantioselective catalytic oxidation of sulfides. In 1997, he joined the CNRS as Chargé de Recherche and is now working at the Centre de Recherche en Cancérologie de Marseille. His research program is focused on the development of novel classes of antimicrobial and anticancer agents.
B. Bussolati University of Turin Torino Italy
K. Camphausen National Cancer Institute MD USA Biography
Biography of K. Camphausen
Kevin Camphausen received his undergraduate degree from Purdue University in 1988. He then completed his MD (1996) and medical internship (1997) at Georgetown University Medical Center. He next completed his residency in Radiation Oncology at the Joint Center of Radiation Therapy at Harvard Medical School (2001). While there, he worked in the laboratory of Dr. Judah Folkman studying the interactions of antiangiogenic therapy and radiotherapy. He joined the Radiation Oncology Branch in 2001 as a tenure track investigator, received tenure in 2007 and was promoted to Chief of the Radiation Oncology Branch (ROB), Center for Cancer Research (CCR), NCI. He is an internationally recognized expert in the field of drug-induced tumor radiosensitization.
M. Caraglia Second University of Naples Naples Italy
N. Cerqueira University of Porto Porto Portugal
F. Chen Fudan University Shanghai, P.R China
P. Chieffi Second University of Naples Naples Italy
L. Cocco University of Bologna Bologna Italy Biography
Biography of L. Cocco
Dr. Cocco is M.D. from the University of Chieti, School of Medicine. After being Visiting Scientist at the Beatson Inst. Cancer Res., Glasgow and at the AFRC Babraham Institute, Cambridge, U.K. is presently Professor, Chair of Anatomy and Head of Cellular Signalling Laboratory at the University of Bologna. Editorial Board: Advances in Biological Regulation Editor-in-Chief of Advances in Biological Regulation, is Board Member of Recent Patents on Anti-Cancer Drug Discovery, Cellular Signalling, Journal of Cellular Biochemistry Founder and First Co-Chairman of the new series of Gordon Research Conference “Signal Transduction Within the Nucleus” He has authored more than 300 full length papers in peer reviewed Journal and has discovered the nuclear signalling via inositol lipid cycle
M.V. Dwek University of Westminster London UK
F. Entschladen MetaVi Labs Witten Germany Biography
Biography of F. Entschladen
Dr. Entschladen studied Biology at the University of Aachen, Germany, and obtained a doctorate in natural sciences at the Witten/Herdecke University, Germany. Dr. Entschladen has more than 20 years of research experience in oncology and published over 70 scientific publications. Currently, Dr. Entschladen is patent manager at the technology transfer agency PROvendis, Germany, and Adjunct Professor at the Witten/Herdecke University. In addition, Dr. Entschladen is co-founder of MetaVì Labs, Austin, TX.
Z. Estrov University of Texas MD Anderson Cancer Center TX USA
R.A. Franklin Brody Sch. of Med. at East Carolina University NC USA
G. Fritz Heinrich Heine University Düsseldorf Düsseldorf Germany
L. Fu Sun Yat-sen University Guangzhou China Biography
Biography of L. Fu
Dr. Fu received Ph. D. degree from Sun Yat-sen University in 1996 and later on becamea professor there. He also stayed in Medical University of South Carolina as postdoctoral fellowship(1999- 2001). His active research fields includereversal multidrug resistance induced by ABC transporters, new drug research and development for treatment of cancer patients, primary cancer tissue culture and test of drug sensitivity for personalized chemotherapy.
He is Chairman of Board of Directors, Guangdong Anticancer Society; Associate Director of Cancer Pharmacology and Chemotherapy Section, Chinese Pharmacological Society, Anticancer Drug Section, Chinese Anticancer Society; Active Member of AACR; Member of Board of Directors, Guangdong Pharmacological Society and Chinese Pharmacological Society.
S. Fulda Goethe-University Frankfurt Frankfurt Germany
M. Galanski University of Vienna Vienna Austria Biography
Biography of M. Galanski
Prof. Dr. Galanski obtained a doctorate (Ph.D.) in Chemistry from the University of Heidelberg, Germany. He holds the position of Associate Professor at the Institute of Inorganic Chemistry of the University of Vienna, Austria. Dr. Galanski has (co)authored more than 150 publications in the field of bioinorganic chemistry with a focus on the development of platinum-based anticancer drugs.
P. Grieb Mossakowski Med. Res. Ctr. Polish Acad. of Sci. Warsaw Poland
T.-C. He The University of Chicago Medical Center IL USA
J.W. Ho The Chinese University of Hong Kong Shatin Hong Kong Biography
Biography of J.W. Ho
Professor Wing Shing (John) Ho, Ph.D., is an associate professor in the Biochemistry Programme of School of Life Sciences at The Chinese University of Hong Kong. He obtained a B.S. from The University of Alberta, and M.A., and a Ph.D. in Biological Chemistry (1985) from State University of New York at Buffalo. After completing a post-doctoral training in Pediatrics Department at SUNYAB and University of Utah. He was appointed associate professor in the School of Life Sciences at The Chinese University of Hong Kong in 1994.
W. Hu University of Texas MD Anderson Cancer TX USA
H.-S. Huang Taipei Medical University Taipei Taiwan Biography
Biography of H.-S. Huang
Dr. Huang obtained a doctorate (Dr. rer. nat.) in Pharmacy from the University of Regensburg, Germany. Dr. Huang was former dean of School of Pharmacy, and head of the Department of Research and Development in NDMC and director of Department of Pharmacy Practice, Tri-Service General Hospital/NDMC. Currently Dr. Huang is a Professor in College of Medical Science and Technology, Taipei Medical University also an Adjunct Professor in NDMC. He has published more than 90 scientific publications and is a named inventor of 30 issued U.S and Taiwan patents.
Dr. Huang is currently the Editorial Advisory Board of this journal, published by Bentham Science Publishers.
H. Hung National Cancer Centre of Singapore Singapore Biography
Biography of H. Hung
Prof. Huynh is an adjunction professor at McGill University, Montreal, Canada and National University Singapore. He is also the Principal Investigator of Laboratory of Molecular Endocrinology at National Cancer Centre since 1999. His research interest is to establish and developthe xenograft models of human solid malignancies: Hepatocellular carcinoma, Gastrointestinal Stromal Tumours, Gastric Cancer, Lung Cancer, Pancreatic Cancer, Breast Cancer, Ovarian Cancer, NPC and Head and Neck cancers from patient’s tumor specimens. He has published as the first or corresponding author in around 125 peer-reviewed journals and has collaborated with various pharmaceutical companies and academic institutions to identify novel treatments.
K.-I. Inoue International University of Health and Welfare Otawara Japan
Y. Keisari Tel Aviv University Tel Aviv Israel Biography
Biography of Y. Keisari
Dr. Keisari obtained Ph.D. and M.Sc. degrees at the faculty of life sciences, Tel Aviv University. He is member of the Dept. of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Israel, since 1979 and is Prof. Emeritus since 2015.
Dr. Keisari is co-author of 88 peer reviewed scientific papers, 6 reviews, 5 chapters in books, edited 2 books, and one patent. He serves as member of editorial board of 6 journals.
Dr. Keisari is one of the founders and past president of the “Israeli Society for Cancer Research” (ISCR), and serves as the treasurer of the “International Cancer Microenvironment Society”. He also serves as the Chief Biomedical Officer of Alpha Tau Medical.
M. Khan Biomedical Research Institute Coventry UK
S.G. Kim Seoul National University Seoul Korea
Y.-H. Kim Korea University Anam Hospital Cancer Center Seoul South Korea Biography
Biography of Y.-H. Kim
Yeul Hong Kim, MD, PhD is Professor of Medical Oncology at the Korea UniversityCollege of Medicine. He is certified in internal medicine and medical oncology by the Korean Association of Internal Medicine.
Dr. Kimis actively involved in the Cancer Genomic research for lung and gastrointestinal cancers using circulating tumor DNA.He currently is theChairman of Board, the Korean Cancer Association and President of Asian Clinical Oncology Society. Currently he is Director of the K-MASTER Cancer Precision Medicine Diagnosis and Treatment Enterprise, which is funded from Korea Ministry of Health and Welfare.
S.V. Kozlov NCI at Frederick MD USA
M. Kriajevska University of Leicester Leicester UK Biography
Biography of M. Kriajevska
Dr. Kriajevska obtained a doctorate (Ph.D.) in Biochemistry from the Moscow State University,Russia. Dr. Kriajevska isa Fellow of the Higher Education Academy and a Fellow in the Institute of Biomedical Science, UK.
Currently Dr. Kriajevska is anHonorary Lecturer in the Leicester Cancer Research Centre (UK) and the Editorial Board memberfor Scientific Reports.
Her research interest is in the field of cancer cell biology with a particular focus on the role of S100 proteins in control of the cytoskeletal rearrangements and cell motility during Epithelial Mesenchymal Transition.
A. Kumar CSIR-Central Drug Research Institute Lucknow India
M.D. Lacher BriaCell Therapeutics Corp. CA USA Biography
Biography of M.D. Lacher
Since July 2015, Dr. Lacher is the Head of Research & Development at BriaCell Therapeutics Corp., animmunotherapy-focused biotechnology company. Previously, he served as a Senior Clinical Scientist, R&D at Cesca Therapeutics, Inc., an autologous cell therapy company;as a Scientist at BioTime, Inc. and its subsidiary OncoCyte Corporation; and as Founder & CEO of T cell Therapeutics, Inc., an immuno-oncology company focused on bispecific antibodies for prostate cancer. Earlier in his career, Dr. Lacher conducted cancer research at the University of California, San Francisco (UCSF). He earned his Ph.D. in 2001 from theUniversity of Bern, Switzerland.
H. Lawnicka Medical University of Lodz Lodz Poland
P. Limonta University of Milan Milan Italy Biography
Biography of P. Limonta
Dr. Limonta obtained a Degree in Pharmaceutical Chemistry and Technology and a Degree in Pharmacy from the University of Milano, Italy. She also holds a Postdoctoral Degree in Pharmacology and a Postdoctoral Degree in Experimental Endocrinology from the University of Milano, Italy. She has been Postdoctoral fellow in Biology of Reproduction at the Population Council, Center for Biomedical Research, New York (1983-1984).
Currently, Dr. Limonta is Associate Professor of Applied Biology, at the University of Milano. She has published 90 scientific peer-reviewed publications, most of them in the field of molecular oncology.
She is currently Editorial Advisory board Member of the journal 'Recent Patents on Anti-Cancer drug Discovery'.
Kun Ping Lu, MD, PhD, is a Professor at Harvard Medical School and the Chief of the Division of Translational Therapeutics at Beth Israel Deaconess Medical Center. He discovers a unique phosphorylation-specific proline isomerase, Pin1 that helps protect against Alzheimer’s disease and whose aberrant activation helps promote the development of cancer. Based on these discoveries, his laboratory is working to develop an antibody therapy for the early diagnosis and treatment of Alzheimer’s and traumatic brain injury, and Pin1 chemical inhibitors to overcome drug resistance in cancer treatments.
B.A. Lwaleed University of Southampton Southampton UK
F. Mannello University "Carlo Bo" of Urbino Urbino Italy
M.P. Marques University of Coimbra Coimbra Portugal Biography
Biography of M.P. Marques
Maria Paula Marques received her MSc in Physical-Chemistry (1987) her PhD (1995) from the Univ. Coimbra. M.P.M. Marquesis currentlya professor at the Dep. Life Sciences of the Univ. Coimbra, assistant-coordinator of the R&D Group “Molecular Physical-Chemistry” and head of the “Chemoprevention, -Therapy & -Toxicology” laboratory. M.P.M. Marques has authored 130 scientific papers, 8book chapters and co-edited 3 books. She is an affiliated member of the Royal Society of Chemistry and of the Clinical Infrared and Raman Spectroscopy for Medical Diagnosis (CLIRSPEC), the Portuguese delegate for the COST Action Raman4Clinics, an associate editor of RSC Advances.
M. McKeage The University of Auckland Auckland New Zealand
L. Messori University of Florence Sesto Fiorentino Italy
Dr. Micheau studied molecular biology and obtained a Ph.D. in 1999 at the University of Bourgogne, Dijon, France. He moved the same year to Jürg Tschopp's laboratory at the department of biochemistry of the University of Lausanne, Switzerland, where he identified the molecular mechanisms underlying TNFR1 death signaling. In 2003 he was awarded a full tenured INSERM position at the University of Bourgogne-Franche-Comté in the Lipid Nutrition and Cancer department (LNC U866), and was appointed director of research in the INSERM unit U866 in 2015. His current research focuses on the characterization of TRAIL signaling.
S. Mocellin University of Padova Padova Italy Biography
Biography of S. Mocellin
Prof. Simone Mocellin obtained his MD degree at the University of Padova, where he specialized in General Surgery in 1998 and he's got a PhD doctorate in Surgical Oncology in 2002. For two years (1999-2001) he worked at the Surgery Branch of the National Cancer Institute of Bethesda (Maryland, USA). Currently he works as consultant surgeon at the Surgical Oncology branch of the Istituto Oncologico Veneto (IOV-IRCCS) of Padova, Italy. He is also professor of surgery at the Dept. Surgery Oncology and Gastroenterology of the University of Padova, Italy. He is the author of more than 160 articles published in peer-review international medical journals. His main interest is surgical oncology with special regard to the surgical treatment and translational research in the fields of cutaneous melanoma, soft tissue sarcomas and gastrointestinal cancers.
F. Mollinedo CSIC-University of Salamanca Salamanca Spain Biography
Biography of F. Mollinedo
Faustino Mollinedo received his Ph.D. in Chemistry in 1982 (Complutense University, Madrid). He then moved to Dartmouth Medical School in Donald L. Schneider’s laboratory (1982-3), where they identified a novel cytoplasmic granule (tertiary granule) in human neutrophils, and then to New York University Medical Center. In 1986 he obtained a tenure position at the Spanish National Research Council, establishing successively his laboratory in Madrid, Valladolid and Salamanca. Now he has moved to the Center for Biological Research in Madrid (2016). His laboratory has made several important contributions in neutrophil biology, ether lipids’ mechanism of action, and apoptosis as a target in cancer therapy. His laboratory identified the translocation of Fas/CD95 death receptor into lipid raft membrane domains as a new mechanism of apoptosis regulation, unveiling rafts as a new target in cancer therapy.
P. Moreau Blaise Pascal University Clermont-Ferrand II France Biography
Biography of P. Moreau
Prof. Pascale Moreau obtained a Master Degree in Biophysicochemistry and Cellular and Molecular Biology, and a Ph.D in Chemistry and Physicochemistry of Compounds with Biological Interest, from the University of Orléans (France). She joined Pr. Victor A. Snieckus’s group at Waterloo University (Canada), working on macrocycles synthesis and directed ortho-metalation. During a second post-doctoral position at Bristol-Myers-Squibb (Marne-la-Vallée, France) she focused on asymmetric synthesis. In 1996, she moved to Blaise Pascal University (Clermont-Ferrand, France) working on hemisynthesis of rebeccamycin derivatives. Her current research is devoted to the development of new bioactive heteroaromatic compounds.
J.-S. Nam Gwangju Institute of Science and Techonology Gwangju Korea Biography
Biography of J.-S. Nam
Dr. Jeong-Seok Nam obtained a doctorate (Ph.D.) in Veterinary Medicine from Seoul National University, Seoul, South Korea. Dr. Nam's research focuses on understanding and targeting cancer metastasis. He is working as an associate professor in school of life sciences, Gwangju Institute of Science and Technology, Gwangju, South Korea. He has published more than 80 scientific publications. He is currently the editorial board member of this journal (Recent Patents on Anti-Cancer Drug Discovery), published by Bentham Science Publishers.
J. Neuzil Griffith University Queensland Australia
E. Papadimitriou University of Patras Patras Greece
V. Pittalà University of Catania Catania Italy Biography
Biography of V. Pittalà
Dr. Pittalà attained her MSc in Chemical and Pharmaceutical Technologies, and subsequently completed her Ph.D. in Pharmaceutical Sciences at the University of Catania. Then, Dr. Pittalà moved to Milan (Italy) to join Pharmacia Corporation as a research scientist. She worked as member of Combinatorial Chemistry Group (R&D) and contributed to the discovery and identification of danusertib being co-inventor of bicyclopyrazoles chemical class. She currently hold the position of Assistant Professor at the University of Catania.
Here major area of interest are the design and synthesis of heme oxygenase-1 inhibitors, and σ receptor ligands as new antitumor agents. Her research resulted in 7 patents, over 60 peer-reviewed papers in prestigious journals. She is also serving as reviewer of several international journals.
M. Provenzano University Hospital Zurich Zurich Switzerland
M.D. Pujol University of Barcelona Barcelona Spain
D. Raucher University of Mississippi Medical Center MS USA
Prof. Luciano Saso is a Member of the Faculty of
Pharmacy and Medicine, Sapienza University of Rome, Italy. He is author of more than 200 original scientific articles
published in peer reviewed international journals with impact factor
working mainly in the field of oxidative stress and antioxidants. He coordinated
several international research projects and has been referee for many national and
international funding agencies and international scientific journals in the last 25
years. He has been Guest Editor of several Special Issues.
N.A. Saunders University of Queensland Queensland Australia Biography
Biography of N.A. Saunders
Associate Professor Nicholas Saunders trained as a pharmacologist at the University of Western Australia under the supervision of Professor Rodney Minchin and Professor Ken Illett. Dr Saunders was then awarded a Fogarty Visiting Fellowship to pursue postdoctoral studies at the National Institute of Environmental Health Sciences in the USA under the supervision of Professor Anton Jetten. In 1993, Dr Saunders was approached by Professor Ian Frazer to return to Australia and set up the Epithelial Pathobiology Group. Since establishing his research group, Dr Saunders has attracted more than $12 million in competitive research funding and has been the recipient of a Lions Medical Research Foundation Senior Research Fellowship, a Garnett Passe and Rodney Williams Memorial Foundation Principal Research Fellowship and is a current Cancer Council Queensland Senior Research Fellowship. Ass Prof Saunders is currently Head of the Epithelial Pathobiology Group within the University of Queensland Diamantina Institute.
E. Segal-Bendirdjian Université Paris Descartes Paris France Biography
Biography of E. Segal-Bendirdjian
Received her MD from Necker Hospital (Paris Descartes University, France) and her PhD in Molecular and cellular Biology from Pierre and Marie Curie University (Paris, France). After working in Molecular and Biological Pharmacology in Gustave-Roussy Institute (Villejuif, France), she obtained a position as a research scientist at CNRS. She joined Saint-Louis Hospital (Paris, France) in 1998 where she became a team leader as a Research Director working on the pharmacological and physiological regulation of the telomerase expression and activity in an INSERM Unit. She joined Paris Descartes University in 2010 where she became the head of INSERM UMR-S 1007 named "Cellular Homeostasis and Cancer".
M.S. Sheikh Upstate Medical University NY USA Biography
Biography of M.S. Sheikh
Dr. M. Saeed Sheikh is a Professor in the Department of Pharmacology at State University of New York, Upstate Medical University, Syracuse, New York, USA. Research activities in Dr. Sheikh’s group are focused on the development of tumor markers and targets for cancer therapy. Work is also ongoing to elucidate the molecular mechanisms regulating cell death and survival signaling in normal and cancer cells to better understand the processes of cancer development and progression, and to develop novel, more efficacious and less toxic anticancer agents. Another related area is focused on genotoxic, ER and metabolic stresses.
X. Sun Harbin Medical University Harbin P.R. China Biography
Biography of X. Sun
Dr Xueying Sun obtained MD and PhD from Shandong University in 1994. He is currently holding a professorial position at the Department of Surgery, the Affiliated Hospital of Harbin Medical University, and a position of Honorary Senior Research Fellow at Department of Molecular Medicine & Pathology, FMHS, University of Auckland. His present research and professional specialities include tumor hypoxia, cancer molecular targeted therapy, cellular signalling and non-coding RNAs. He was a winner of World Health Organization Fellowship (1999-2000) and Wellcome Trust Leave Fellowship (2001-2005). He has published over 200 research articles in peer-viewed journals including 120 articles in Science Citation Index journals. He is also a member of Editorial board of five academic journals, and a member of the review panels for National Natural Scientific Foundation, Ministry of Science and Technology and Ministry of Education of China.
A. Toninello University of Padova Padova Italy
G. Tonini University Campus Bio-Medico Rome Italy Biography
Biography of G. Tonini
Prof. Tonini, MD PhD, is Full Professor of Medical Oncology and Chief of the Division of Medical Oncology at Campus Bio-Medico University Hospital of Rome. He is Coordinator of the Degree Course in Medicine and Surgery, Director of the Post-Graduated School in Medical Oncology, Professor at Phd School of Integrated Biomedical Science and Bioethics and Director of the Translational Oncology Research Laboratory.
Current fields of investigation include clinical and molecular aspects of solid tumors, with particular attention to colorectal cancer, biliary tract cancer, bone metastases and palliative care in cancer.
Prof. Tonini is member of the Editorial Board or Editor in Chief of numerous high-ranked international journals and he has authored over 350 peer-reviewed manuscripts, reviews and book chapters on International Journals.
E. Tulchinsky University of Leicester Leicester UK
J. Tyndall University of Otago Dunedin New Zealand Biography
Biography of J. Tyndall
Joel Tyndall leads a research group at the University of Otago in New Zealand. He obtained his doctorate from the University of Queensland in drug design in 2000. His research involves drug discovery in the areas of cancer and infectious diseases as well as the understanding of resistance mechanisms in infectious diseases.
L. Dalla Via University of Padova Padova Italy Biography
Biography of L. Dalla Via
Dr. Dalla Via obtained the degree in Biological Sciences with full marks cum laude and a doctorate (Ph.D.) in Biochemistry and Biophysics from the University of Padova, Italy. Currently Dr. Dalla Via is associate professor in the Department of Pharmaceutical and Pharmacological Sciences of the University of Padova. She has published 96 scientific publications.
G. Vitale University of Milan Milan Italy
M. Watanabe Yokohama National University Tokiwadai Japan Biography
Biography of M. Watanabe
Dr.Watanabe graduated from Yokohama National University, Faculty of Engineering, and Mie University, Faculty of Medicine. He obtained a doctor in Medicine from Mie University. He is also a guest professor, Yokohama City University. He has published more than 100 scientific publications.
T. Watanabe Tokyo University School of Medicine Tokyo Japan
D. Wolowiec Medical University of Wroclaw Wroclaw Poland Biography
Biography of D. Wolowiec
Prof. Dariusz Wołowiec, MD, PhD, is graduated from the Faculty of Medicine, Wrocław Medical University, Poland. He holds a certification as a specialist in internal medicine, hematology and transplantation medicine. Currently he is appointed full-time professor in the Department of Hematology of Wrocław Medical University. In 1996-97 and 1992-95 he underwent a research training in Analytical Cytology Laboratory, Lyon I University, Lyon, France, where he obtained the doctorate (PhD) in Differentiation, Genetics and Immunology. He is an author or co-author of more than 100 publications in Polish and international peer-reviewed journals. His main field of interest is clinical and biological hematology, in particular lymphoid malignancies.
K.K. Wong The University of Texas M. D. Anderson Cancer Center TX USA
K. Ye State University of New York AR USA
X. M. Yuan Linköping University Hospital Linkoping Sweden Biography
Biography of X. M. Yuan
Dr. Xi-Ming Yuan received his M.D. in 1984 from Jilin Medical College in China and a Ph.D. degree in internal medicine 1997 from Linkoping University, Sweden. Year 2006 he has been appointed Associate Professor in Experimental Pathology by Faculty of Medicine and Health Sciences, Linköping University. He has published more than 70 scientific publications in SCI that are cited > 1572 times with a h-index 23.
Associate Editorial Board Member
S.G. Vitale University of Catania Catania Italy Biography
Biography of S.G. Vitale
Salvatore Giovanni Vitale M.D. Ph.D was born in Catania (Italy) on 30th August 1984. He graduated in Medicine and Surgery with full marks and honours at the University of Catania (Italy) in 2009 and specialised in gynecology and obstetrics with honours in 2015. He obtained a Ph.D. in Medical and Surgical Biotechnologies from the University of Messina (Italy) in 2018 and the national qualification to associate professor. Currently, he is attending the International Master Degree in “Gynecologic Oncology” at the Catholic University of the Sacred Heart in Rome.
His main research interests are: intracavitary uterine pathology (including malignant pathology), reproductive biology, hysteroscopy, chronic pelvic pain and gynecological endocrinology. He is author of several scientific articles published in national and international peer-reviewed journals as well as of national and international monographs and book chapters, also used as reference texts in degree courses in medicine and health professions.